Brain Metastasis after a Gastrectomy for Gastric Cancer.
10.5230/jkgca.2001.1.2.113
- Author:
Yong Il KIM
1
;
Jun Ho LEE
;
Seong Hyeon YUN
;
Sung Hoon NOH
;
Jin Sik MIN
Author Information
1. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea. sunghoonn@yumc.yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
Gastric cancer;
Brain metastasis
- MeSH:
Blood Vessels;
Brain*;
Classification;
Diagnosis;
Early Diagnosis;
Follow-Up Studies;
Gastrectomy*;
Headache;
Hope;
Humans;
Incidence;
Lymphatic Vessels;
Neoplasm Metastasis*;
Neurologic Manifestations;
Prognosis;
Retrospective Studies;
Stomach Neoplasms*
- From:Journal of the Korean Gastric Cancer Association
2001;1(2):113-128
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The common features of brain metastases from gastric cancer are unknown because brain metastasis is an uncommon pattern of metastasis. The purpose of this study was to investigate the clinical features of and the prognosis for patients with brain metastases after a curative resection for gastric cancer. MATERIALS AND METHODS: Twenty-one (21) cases of patients with brain metastases of gastric cancer, who had been treated at the Department of Surgery, Yonsei University College of Medicine, were assessed retrospectively. RESULTS: The mean age was 55.8+/-9.6 years (range: 34~70 years), and the male-to-female ratio was 2.5:1. The most common neurologic symptom was headache (38.5%), and no patient was free from the neurologic symptoms. The incidence of parenchymal metastasis (PM: 76.2%) was higher than that of leptomeningeal metastasis (LM: 19.0%). Patients with gastric cancer and brain metastasis showed high rates of blood and lymphatic vessel invasion (lymphatic vessel invasion: 85.7%; blood vessel invasion: 80.9%). According to Lauren's classification, the incidence of intestinal types was 14/21 (66.7%), that of diffuse types was 3/21 (14.3%) and that of mixed types was 4/21 (19.0%). The mean interval between the gastrectomy and the diagnosis of brain metastasis was 24.7+/-4.0 months (PM: 26.8 months; LM: 20.3 months). The median period of survival after diagnosis of brain metastasis was 2 months for paren chymal metastasis and 0 months for leptomeningeal metastasis. CONCLUSION: During a follow-up period, patients with neurologic symptoms should be suspected of having brain metastasis. Early diagnosis and treatment is the only hope to prolong survival in such patients.
